1. Mahakkanukrauh, A, Chaiamnuay, S, Koolvisoot, A, Kitamnuayphong, T, Manavathongchai, S, Osiri, M et al.. Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand. Immunotherapy. 2023;15 (14):1143-1155. doi: 10.2217/imt-2022-0290. PubMed PMID:37589164 .
  2. Intapiboon, P, Pinpathomrat, N, Juthong, S, Uea-Areewongsa, P, Ongarj, J, Siripaitoon, B et al.. Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines (Basel). 2023;11 (3):. doi: 10.3390/vaccines11030537. PubMed PMID:36992120 PubMed Central PMC10054473.
  3. Uea-Areewongsa, P, Pinpathomrat, N, Ongarj, J, Sophonmanee, R, Seepathomnarong, P, Seeyankem, B et al.. Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases. Asian Pac J Allergy Immunol. 2023; :. doi: 10.12932/AP-280722-1420. PubMed PMID:36592166 .
  4. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  5. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  6. Siripaitoon, B, Lertwises, S, Uea-Areewongsa, P, Khwannimit, B. A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality. Lupus. 2015;24 (1):98-106. doi: 10.1177/0961203314548884. PubMed PMID:25149601 .
  7. Kwankaew, J, Leelawattana, R, Saignam, A, Siripaitoon, B, Uea-Areewongsa, P, Juthong, S et al.. Apolipoprotein B as an independent predictor of arterial stiffness in systemic lupus erythematosus patients. Int J Rheum Dis. 2015;18 (4):447-51. doi: 10.1111/1756-185X.12384. PubMed PMID:24797872 .
  8. Uea-areewongsa, P, Chaiamnuay, S, Narongroeknawin, P, Asavatanabodee, P. Factors associated with osteonecrosis in Thai lupus patients: a case control study. J Clin Rheumatol. 2009;15 (7):345-9. doi: 10.1097/RHU.0b013e3181ba3423. PubMed PMID:20009970 .
Search PubMed